Compare STZ & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STZ | IQV |
|---|---|---|
| Founded | 1945 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Beverages (Production/Distribution) | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.2B | 28.6B |
| IPO Year | 1994 | 2013 |
| Metric | STZ | IQV |
|---|---|---|
| Price | $150.70 | $172.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 16 |
| Target Price | $172.63 | ★ $230.56 |
| AVG Volume (30 Days) | ★ 1.7M | 1.2M |
| Earning Date | 04-08-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.65% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | N/A | ★ 7.84 |
| Revenue | ★ $10,208,700,000.00 | $9,739,000,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | $0.48 | $5.87 |
| P/E Ratio | $24.93 | ★ $21.79 |
| Revenue Growth | 2.48 | ★ 41.60 |
| 52 Week Low | $126.45 | $134.65 |
| 52 Week High | $196.91 | $247.05 |
| Indicator | STZ | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 46.56 | 50.68 |
| Support Level | $149.01 | $159.42 |
| Resistance Level | $154.03 | $193.26 |
| Average True Range (ATR) | 3.81 | 6.17 |
| MACD | 0.34 | 1.66 |
| Stochastic Oscillator | 32.17 | 63.81 |
Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating 84% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 10% stake in Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.